Blood pressure pattern and heart rate variability in normotensive patients with type 2

Size: px
Start display at page:

Download "Blood pressure pattern and heart rate variability in normotensive patients with type 2"

Transcription

1 Blood pressure pattern and heart rate variability in normotensive patients with type 2 Diabetes Mellitus Laura Poanta 1, Anca Cerghizan 2, Dana Pop 3 1 University of Medicine and Pharmacy Iuliu Hatieganu Cluj Napoca, Second Department of Internal Medicine 2 County Hospital Cluj, Diabetes Center Cluj-Napoca 3 University of Medicine and Pharmacy Iuliu Hatieganu Cluj Napoca, Department of Cardiac Prevention and Rehabilitation Corresponding author: Laura Poanta, MD, Office Address: Clinicilor street 2-4, postal code , Cluj Napoca, ROMANIA Home address: Nicolae Pascaly 9/16, zip code , Cluj Napoca, ROMANIA Phone , laurapoanta@yahoo.com

2 Abstract Background: ambulatory blood pressure monitoring (ABPM) has shown that almost one third of presumed normotensive patients with type 2 diabetes mellitus have instead masked hypertension. There is also a relationship between cardiovascular autonomic neuropathy and blood pressure patterns even in normotensive patients with diabetes mellitus. The aim of the present study was to analyze the blood pressure patterns in type 2 diabetic patients without any history of hypertension and to establish the connection between heart rate variability parameters, ultrasound parameters and ABPM parameters. Material and methods: Fifty-two subjects with type 2 diabetes, aged 59 (±6), were consecutively recruited at the internal medicine department of the County Hospital from Cluj. Informed consent was obtained from all participants. A control group of 47 subjects, age and sex matched, was also analyzed. Results: More than half of the patients had a non-dipping pattern, despite the fact that they are considered normotensive patients. Heart rate variability parameters are lower in the nondipping group, but the difference is significant only for vagal activity. Left ventricle is thicker in non-dipping group. The mean age of the non-dipping group (61.23 ±2.02 years) was significantly higher than the age of the dipping group (55.11 ±3.88 years) (p<0.01). Discussions and conclusion: we found a great number of patients with diabetes mellitus and with altered patterns of blood pressure, even if they were previously considered as normotensive. The non-dipping pattern is associated with abnormal values of heart rate variability parameters and with thicker left ventricle walls, but the differences are not always statistical significant. It is important to closely monitorize the patients with diabetes mellitus even if they have normal office blood pressure determinations, mainly those with a history of more than 5 years of the disease. Acknowledgement: Research supported by the CNCSIS project number 1277 of the Romanian Ministry of Education and Research

3 Ambulatory blood pressure monitoring (ABPM) has shown that almost one third of presumed normotensive patients with type 2 diabetes mellitus have instead masked hypertension [1]. The thickness of inter-ventricular septum and posterior wall were significantly increased in these patients, as compared with confirmed normotensive patients. ABPM is important for identifying these high-risk patient groups and ensuring early interventions. Also, left ventricle hypertrophy parameters are greater among hypertensive patients with diabetes mellitus, as they had a higher rate of non-dipping pattern. Another study showed that only night-time systolic blood pressure (BP) is associated with cardiovascular and cerebro-vascular morbidity and mortality, in hypertensive patients with type 2 diabetes mellitus [2]. Pulse pressure is another parameter which proved itself very useful in mortality prediction, but also when measured by ABPM. [3]. ABPM allows the evaluation of some important BP parameters such as the 24-h general mean, daytime and nighttime systolic and diastolic BP means, BP loads and the absence of nocturnal drop of BP (dipping), as well as the identification of white-coat and masked hypertension. [4] On the other hand, there is a relationship between cardiovascular autonomic neuropathy and blood pressure patterns even in normotensive patients with diabetes mellitus, autonomic imbalance being associated with abnormal patterns of 24-hours blood pressure measurements (non-dipping pattern, higher values of nocturnal blood pressure) [5-8]. The aim of the present study was to analyze the blood pressure patterns in type 2 diabetic patients without any history of hypertension and to establish the connection between heart rate variability parameters (as the expression of autonomic balance), ultrasound parameters (accounting for left ventricle dimensions) and ABPM parameters.

4 Material and methods Fifty-two subjects with type 2 diabetes, aged 59 (±6), were consecutively recruited at the internal medicine department of the County Hospital from Cluj. Informed consent was obtained from all participants. A control group of 47 subjects, age and sex matched, was also analyzed. Inclusion criteria were: age under 65 years and values of casual BP within normal range (<140/90 mm Hg) without antihypertensive treatment. Exclusion criteria were: impaired renal function, clinically significant abnormality of hepatic, haemopoietic, respiratory or endocrine function, history and/or evidence of cerebrovascular or coronary heart disease, arrhythmias, antihypertensive treatment and use of any other medication affecting cardiovascular or autonomic nervous function. BP monitoring Non-invasive 24-h ambulatory BP monitoring (ABPM) was performed using an oscillometric recorder. The device was programmed to measure BP every 20 minutes on daytime and every 30 minutes on nighttime, for 24 h. Patients were hospitalized and were following the hospital routines, which allowed a better standardization of recording conditions. Only the 24-h recordings that contained a percentage of measurement errors under 30% were accepted as valid. Systolic (SBP) and diastolic BP (DBP) measurements were averaged for the day and the night periods, according to reported time of waking up and going to bed (6 a.m. and 10 p.m., respectively). The percentage change from day to night in BP was calculated as: (day BP night BP) 100/day BP. Non-dipper pattern is defined as a reduction with less than 10% from the daytime mean, or a day/night ratio over 0.9. Blood pressure was also measured with a classical sphyngomanometer at two different moments, in the morning (awake BP, at 6 a.m.) and in the evening (asleep BP, at 10 p.m.), at the

5 same hour for all the patients. We created two sub groups (dippers and non-dippers) and we compared the results. Heart rate variability HRV was measured using a 24-hour ECG monitoring system (Holter Digital recorder AsPEKT 812) in all subjects during normal daily activity. Time domain parameters used are: SDNN expressed in milliseconds (ms) accounts for standard deviation of all NN intervals. SDANN expressed in ms accounts for standard deviation of the averages of NN intervals in all 5 min segments of the entire recording. pnn50 % is the number of pairs of adjacent NN intervals divided by the total number of all NN intervals. Frequency domain parameters used are: low frequency and high frequency components of spectral analysis expressed in squared milliseconds (ms 2 or normalized units). Echocardiography Standard two dimensional and Doppler echocardiography was performed in all the subjects. The standard views and the measurements of heart chambers were performed according to American Society of Echocardiography recommendations [9] and the same clinician performed all the examinations. The following parameters were obtained for the study: left ventricular diastolic diameter, left ventricular systolic diameter, inter-ventricular septum thickness (IVST) and posterior wall thickness (PWT), expressed in millimeters. Statistical analysis Continuous variables were expressed as mean (SD). Differences were tested for significance by unpaired Student s t test. Upper and lower 95% confidence limits for each variable were calculated from the two tails of the Student s t test distribution. We compared the results among the study group and with control group. A p value <0.05 was considered

6 significant. Pearson correlation coefficients were used to explore linear relationships between the study variables. Statistics were performed with SPSS for Windows, version Results General characteristics of the DM patients are shown in table 1. Place for Table 1 Characteristics of the DM patients between the two subgroups, dippers and non-dippers, are shown in table 2. Place for table 2 Heart rate variability parameters in dippers and non-dippers are shown in table 3. Place for table 3 More than half of the patients had a non-dipping pattern, despite the fact that they are considered normotensive patients. The mean values obtained with ABPM are higher in nondipping group, but the differences are not statistically significant; Δ day - night (%) parameter is significantly affected in non-dippers, but regarding only systolic blood pressure. The awake systolic BP was not significantly different between the dipping and the non-dipping groups (p>0.05; table 2), but the awake diastolic BP in the non-dipping group was lower (p=0.03). The asleep systolic BP and diastolic BP were, as expected, both significantly higher in the nondipping group (p<0.05). The mean age of the non-dipping group (61.23 ±2.02 years) was significantly higher than the age of the dipping group (55.11 ±3.88 years) (p<0.01) (table 2). Weight, body mass index (BMI) and duration of diabetes were also significantly higher in nondippers (table 2). Glycemic control and diabetes treatment did not differ significantly between the two groups. The total cholesterol concentration was significantly lower in the non-dipping group concentrations.

7 Heart rate variability parameters There are differences between the two groups regarding HRV parameters, but only for HF and HF n.u. (as the expression of parasympathetic activity) the differences are statistical significant (table 3). There are strong positive correlations between HF values and Δ day - night (%) parameter (only regarding systolic blood pressure) (r = 0.54) and also between HF and HF n.u. and office diastolic blood pressure measured in the evening (r = 0.60 and 0.58, respectively). Ultrasound parameters Left ventricular diameters, inter-ventricular septum thickness and end-diastolic posterior wall thickness are greater among patients with type 2 diabetes and non-dipper patterns of blood pressure, but the differences are not statistically significant (table 2). Discussions Only few data are available on the factors involved in 24-h BP pattern in type 2 diabetic patients, [10, 11, 12, 13] and generally include both normotensive and hypertensive patients. A conclusive link between abnormal circadian rhythm of BP and autonomic neuropathy has not been established yet. Lower HRV parameters were found to be related to mean 24-h SBP and our study supports this connection. Recent data tend to indicate a significant relationship between hypertension and autonomic neuropathy in diabetes both in the sense of a correlation of SBP to autonomic test impairment [14, 15] and in the suggestion of hypertension as a risk factor for peripheral neuropathy [16, 17]. HF and HF n.u. (which account for vagal activity) were in fact the only parameters of HRV which significantly correlates with non-dipping pattern in our study, although all the HRV parameters were lower in non-dipping group, suggesting impaired cardiovascular autonomic functioning.

8 Our study has considered only normotensive type 2 diabetic patients, most of them (over 50%) showing a non-dipping nocturnal pattern of BP, especially in those with abnormal HRV. The differences between groups involved both SBP and DBP, but in slightly different manners. The decision to exclude type 2 diabetic patients with hypertension or other cardiovascular disease was based on the need to avoid factors potentially interfering with autonomic function assessment such as hypertensive drugs or diseases affecting cardiovascular system [18]. Thus, we cannot exclude that with the occurrence of cardiovascular disease, further factors beyond autonomic function could affect BP circadian pattern in type 2 diabetic patients, as stated in other studies. [19] Qualitative and quantitative differences in daily activities or nocturnal sleep can affect BP monitoring. In this study day and night periods were fixed intervals. ABPM was performed when patients were hospitalized, thus allowing a better standardization of recording conditions in particular with regard to physical activity [19]. The present study has demonstrated that non-dipping of nocturnal blood pressure in people with type 2 diabetes was strongly associated with increasing age and with a longer disease duration. Other studies (by Nakano et al. [20] and Sturrock et al. [21]) have shown an association between increasing age and non-dipping status in people with diabetes. Of course, determination of the true duration of diabetes is difficult, as type 2 diabetes often remains subclinical for many years before the diagnosis. In a previous study, glycemic control correlated with non-dipping, with higher levels of glycemic control observed in non-dippers [22]. In our study, also the glycemic control was associated with non-dipping pattern, but the difference was not statistically significant. The total cholesterol level was significantly lower in the non-dipping cohort, but triglyceride and high-density lipoprotein levels were not significantly different between the two

9 groups. This may reflect the higher incidence of the use of statins in the non-dippers. It was also apparent that non-dipping status was associated with increased body weight and BMI. Non-dipping of nocturnal blood pressure is of prognostic importance. Evidence suggests that a blunted reduction in the normal nocturnal blood pressure fall may play a pivotal role in the development of target organ damage [23, 24, 25] such as left ventricular hypertrophy, which is a powerful predictor of cardiovascular mortality [26, 27]. Also in our study, non-dipping pattern was associated with higher values of left ventricle diameters and wall thickness, but the differences between those and dipping pattern were not statistically significant. Conclusions: Blood pressure determination by ABPM is capable of identifying more adequately stratifying patients at risk for developing chronic complications of DM, and has become an indispensable instrument for BP measurement in these patients. It is of a great importance the fact that blood pressure patterns are modified even in normotensive patients especially associated with heart rate variability changes.

10 References 1. Leitao CB, Canani LH, Kramer CK et al. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients. Diabetes Care. 2007; 30: Carmona J, Amado P, Vasconcelos N et al. Prognostic markers in treated hypertensive diabetic patients. 28-month follow-up. Rev Port Cardiol. 2004; 23: Mannucci E, Lambertucci L, Monami M et al. Pulse pressure and mortality in hypertensive type 2 diabetic patients: a cohort study. Diabetes Metab Res Rev. 2006; 22: Leitao CB, Canani LH, Silveiro SP, Gross JL. Ambulatory Blood Pressure Monitoring and Type 2 Diabetes Mellitus. Arq Bras Cardiol 2007; 88(2): Hansen KW, Mau Pedersen M, Marshall SM, Christiansen JS, Mogensen CE. Circadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia 1992; 35: Benhamou PY et al. Early disturbances of ambulatory blood pressure load in normotensive type 1 diabetic patients with microalbuminuria. Diabetes Care 1992; 15: Lurbe A et al. Altered blood pressure during sleep in normotensive subjects with type 1 diabetes. Hypertension 1993; 21: Torffvit O, Agardh C-D. Day and night variation in ambulatory blood pressure in type 1 diabetes mellitus with nephropathy and autonomic neuropathy. J Intern Med 1993; 233: ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR Appropriateness criteria for trans-thoracic and trans-esophageal echocardiography. JACC 2007; from Nakano S et al. Circadian rhythm of blood pressure in normotensive NIDDM subjects. Diabetes Care 1991; 14: Nielsen FS et al. On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes 1995; 44:

11 12. Pinkney JH et al. The relationship of urinary albumin excretion rate to ambulatory blood pressure and erythrocyte sodium-lithium countertransport in NIDDM. Diabetologia 1995; 38: Jermendy G et al. Day-night blood pressure variation in normotensive and hypertensive NIDDM patients with asymptomatic autonomic neuropathy. Diabetes Res Clin Pract 1996; 34: Maser RE et al. Diabetic autonomic neuropathy and cardiovascular risk. Arch Intern Med 1990; 150: Spallone V, Maiello MR, Cicconetti E, Menzinger G. Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes. Diabetes Res Clin Pract 1997; 34: Forrest K Y Z et al. Hypertension as a risk factor for diabetic neuropathy. A prospective study. Diabetes 1997; 46: Adler Al et al. on behalf of the UKPDS Group. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: Kronert K et al. Influence of cardiovascular diseases upon the results of the cardiovascular reflex tests in diabetic and nondiabetic subjects. Acta Diabetol Lat 1990; 27: Spallone V, Maiello MR, Cicconetti E, Pannone A, Barini A, Gambardella S. Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes. J Human Hypertens 2001; 15: Nakano S. Fukuda M, Hotta F et al. Reversed circadian blood pressure rhythm is associated with the occurrence of both fatal and non-fatal vascular events in NIDDM subjects. Diabetes 1998; 47: Sturrock ND, George E, Pound N, Stevenson J, Peck GM, Sowter H. Non-dipping circadian blood pressure and renal impairment associated with increased mortality in diabetes mellitus. Diabet Med 2000; 17:360-4.

12 22. Björklund K, Lind L, Andrén B, Lithell H. The majority of non-dipping men do not have increased cardiovascular risk: a population-based study. Am J Hypertens 2002; 20: Pickering TG, Kario K. Nocturnal non-dipping: what does it augur? Curr Opin Nephrol Hypertens 2001; 10: Cuspidi C, Macca G, Sampieri L et al. Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J Hypertens 2001; 19: Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti-Rosei E. Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens 1992; 5: Schillaci G, Verdecchia P, Porcellati C et al. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: Sommerfield AJ, Robinson L, Padfield PL, Strachan MWJ. Clinical variables associated with non-dipping of nocturnal blood pressure in type 2 diabetes. Br J Diabetes Vasc Dis 2008; 8:

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,

More information

How To Know If You Have Microalbuminuria

How To Know If You Have Microalbuminuria 3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate

More information

Guidelines for the management of hypertension in patients with diabetes mellitus

Guidelines for the management of hypertension in patients with diabetes mellitus Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

How To Determine The Prevalence Of Microalbuminuria

How To Determine The Prevalence Of Microalbuminuria Research Journal of Pharmaceutical, Biological and Chemical Sciences Prevalence of Microalbuminuria in relation to HbA1c among known Type2 Diabetic Patients in Puducherry population Muraliswaran P 1 *,

More information

Twenty-four Hour Ambulatory Holter Monitoring and Heart Rate Variability in Healthy Individuals

Twenty-four Hour Ambulatory Holter Monitoring and Heart Rate Variability in Healthy Individuals ORIGINAL ARTICLE JIACM 2005; 6(2): 136-41 Twenty-four Hour Ambulatory Holter Monitoring and Heart Rate Variability in Healthy Individuals SH Talib*, PY Mulay**, AN Patil*** Abstract The study focuses on

More information

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* 71 GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* Ryuichi KIKKAWA** Asian Med. J. 44(2): 71 75, 2001 Abstract: Diabetic nephropathy is the most devastating complication of diabetes and is now the

More information

Corporate Medical Policy Ambulatory Blood Pressure Monitoring

Corporate Medical Policy Ambulatory Blood Pressure Monitoring Corporate Medical Policy Ambulatory Blood Pressure Monitoring File Name: Origination: Last CAP Review: Next CAP Review: Last Review: ambulatory_blood_pressure_monitoring 7/1982 4/2016 4/2017 4/2016 Description

More information

Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost

Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost Naftali Stern Institute of Endocrinology, Metabolism and Hypertension Tel Aviv -Sourasky Medical Center and Sackler

More information

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke

More information

The Hypertension Treatment Center

The Hypertension Treatment Center Patricia F. Kao MD MS Asst Professor, EVMS Nephrology & HTN April 26, 2014 The Hypertension Treatment Center I have no conflicts of interest to disclose Objectives Describe the role of Hypertension Treatment

More information

Cardiovascular Risk in Diabetes

Cardiovascular Risk in Diabetes Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,

More information

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Number 84 Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Summary Overview Clinical

More information

Microalbuminuria, Nondipping and Diastolic Dysfunction in Normotensive Type 2 Diabetic Patients

Microalbuminuria, Nondipping and Diastolic Dysfunction in Normotensive Type 2 Diabetic Patients Turkish Journal of Endocrinology and Metabolism, (2003) 1 : 23-29 ORGINAL ARTICLE Microalbuminuria, Nondipping and Diastolic Dysfunction in Normotensive Type 2 Diabetic Patients Mehtap Cakir* Nilgün Baskal**

More information

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years

More information

Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.

Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Associate Investigator Palo Alto Medical Foundation Research Institute Consulting Assistant

More information

MEDICAL POLICY SUBJECT: AUTOMATED AMBULATORY BLOOD PRESSURE MONITORING

MEDICAL POLICY SUBJECT: AUTOMATED AMBULATORY BLOOD PRESSURE MONITORING MEDICAL POLICY SUBJECT: AUTOMATED AMBULATORY 02/19/09 PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product covers

More information

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D. TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type

More information

ECG may be indicated for patients with cardiovascular risk factors

ECG may be indicated for patients with cardiovascular risk factors eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,

More information

ARTICLE. Abstract. Introduction. Materials and methods. Table 1 - Interval from the date of transplantation

ARTICLE. Abstract. Introduction. Materials and methods. Table 1 - Interval from the date of transplantation 47 ARTICLE 24-hours ambulatory blood pressure (ABP) monitoring in renal transplant recipients R Ravichandran, SM Rao, T Rengarajan Madras Institute of Nephrology, Vijaya Health Center, Chennai Abstract

More information

Chronic Daily Headache and Blood Pressure Interrelated Prognosis

Chronic Daily Headache and Blood Pressure Interrelated Prognosis Blood pressure behaviour in chronic daily headache IJM Benseñor, PA Lotufo, D Mion-Jr & MA Martins Department of Medicine, School of Medicine of the University of São Paulo, São Paulo, Brazil Benseñor

More information

Non-Invasive Risk Predictors in (Children with) Pulmonary Hypertension

Non-Invasive Risk Predictors in (Children with) Pulmonary Hypertension Ideal risk prognosticator Easy to acquire Non-Invasive Risk Predictors in (Children with) Pulmonary Hypertension Safe -- Non-invasive Robust Gerhard-Paul Diller Astrid Lammers Division of Adult Congenital

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY Measure #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS F INDIVIDUAL MEASURES:

More information

3 rd Russian-Bavarian Conference on Bio-Medical Engineering

3 rd Russian-Bavarian Conference on Bio-Medical Engineering 3 rd Russian-Bavarian Conference on Bio-Medical Engineering Blood Pressure Estimation based on Pulse Transit Time and Compensation of Vertical Position Dipl.-Inform. Med. Christian Douniama Dipl.-Ing.

More information

Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks

Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks Background: Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks Final Background and Scope November 19, 2015 The Centers for Disease Control

More information

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized

More information

Barry P McGrath, and on behalf of the National Blood Pressure Advisory Committee of the National Heart Foundation of Australia

Barry P McGrath, and on behalf of the National Blood Pressure Advisory Committee of the National Heart Foundation of Australia Information from the For more information contact Heartline 1300 362 787 or www.heartfoundation.com.au Ambulatory blood pressure monitoring Position Statement Barry P McGrath, and on behalf of the National

More information

Atherosclerosis of the aorta. Artur Evangelista

Atherosclerosis of the aorta. Artur Evangelista Atherosclerosis of the aorta Artur Evangelista Atherosclerosis of the aorta Diagnosis Classification Prevalence Risk factors Marker of generalized atherosclerosis Risk of embolism Therapy Diagnosis Atherosclerosis

More information

ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE

ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE I- BACKGROUND: Coronary artery disease and stoke are the major killers in the United States.

More information

Ambulatory blood pressure monitoring

Ambulatory blood pressure monitoring STATEMENT POSITION STATEMENT Ambulatory blood pressure monitoring Barry P McGrath, and on behalf of the National Blood Pressure Advisory Committee of the National Heart Foundation of Australia THE DEVELOPMENT

More information

ASSOCIATED FACTORS OF EJECTION FRACTION IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES

ASSOCIATED FACTORS OF EJECTION FRACTION IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES Rev. Med. Chir. Soc. Med. Nat., Iaşi 204 vol. 8, no. 4 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS ASSOCIATED FACTORS OF EJECTION FRACTION IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES Gina Botnariu

More information

Medical Statistics, School of Medicine, University of Athens, Greece

Medical Statistics, School of Medicine, University of Athens, Greece Original Research Hellenic J Cardiol 2012; 53: 432-438 Circadian Variation of Blood Pressure and Heart Rate in Normotensives, White-Coat, Masked, Treated and Untreated Hypertensives Eleni Koroboki 1, Efstathios

More information

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY In order to improve the efficiency of PINNACLE Registry data analytics, a missing data analysis has been conducted on PINNACLE Registry data

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology

More information

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE

ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE I. PURPOSE To establish guidelines for the monitoring of antihypertensive therapy in adult patients and to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy resident.

More information

Atrial Fibrillation An update on diagnosis and management

Atrial Fibrillation An update on diagnosis and management Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.

More information

Cardiovascular Disease in Diabetes

Cardiovascular Disease in Diabetes Cardiovascular Disease in Diabetes Where Do We Stand in 2012? David M. Kendall, MD Distinguished Medical Fellow Lilly Diabetes Associate Professor of Medicine University of MInnesota Disclosure - Duality

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

Prevalence of microalbuminuria among sudanese type 2 diabetic patients at elmusbah center at ombadda - omdurman

Prevalence of microalbuminuria among sudanese type 2 diabetic patients at elmusbah center at ombadda - omdurman IOSR Journal of Pharmacy ISSN: 2250-3013, www.iosrphr.org Volume 2 Issue 5 Sep-Oct. 2012 PP.51-55 Prevalence of microalbuminuria among sudanese type 2 diabetic patients at elmusbah center at ombadda -

More information

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION European Medicines Agency London, 19 July 2007 Doc. Ref. EMEA/CHMP/EWP/311890/2007 COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR

More information

Blood Pressure. Blood Pressure (mm Hg) pressure exerted by blood against arterial walls. Blood Pressure. Blood Pressure

Blood Pressure. Blood Pressure (mm Hg) pressure exerted by blood against arterial walls. Blood Pressure. Blood Pressure Blood Pressure Blood Pressure (mm Hg) pressure exerted by blood against arterial walls Systolic pressure exerted on arteries during systole Diastolic pressure in arteries during diastole 120/80 Borderline

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION European Medicines Agency Pre-Authorisation Evaluation of Medicines for Human Use London, 25 September 2008 Doc. Ref. EMEA/CHMP/EWP/311890/2007 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE

More information

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate

More information

Diabetes Complications

Diabetes Complications Managing Diabetes: It s s Not Easy But It s s Worth It Presenter Disclosures W. Lee Ball, Jr., OD, FAAO (1) The following personal financial relationships with commercial interests relevant to this presentation

More information

Normal ranges of left ventricular global longitudinal strain: A meta-analysis of 2484 subjects

Normal ranges of left ventricular global longitudinal strain: A meta-analysis of 2484 subjects Normal ranges of left ventricular global longitudinal strain: A meta-analysis of 2484 subjects Teerapat Yingchoncharoen MD. Shikar Agarwal MD. MPH. Thomas H. Marwick MBBS. Ph.D. MPH. Cleveland Clinic Foundation

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

A Study on The Prevalence of Cardiac Autonomic Neuropathy in Type-2 Diabetes in Eastern India

A Study on The Prevalence of Cardiac Autonomic Neuropathy in Type-2 Diabetes in Eastern India ORIGINAL ARTICLE JIACM 2010; 11(3): 190-4 A Study on The Prevalence of Cardiac Autonomic Neuropathy in Type-2 Diabetes in Eastern India Abstract AK Basu*, R Bandyopadhyay**, S Chakrabarti***, R Paul****,

More information

Hypertension and Diabetes

Hypertension and Diabetes Hypertension and Diabetes C.W. Spellman, D.O., Ph.D., FACOI Professor & Associate Dean Research Dir. Center Diabetes & Metabolic Disorders Texas Tech University Health Science Center Midland-Odessa, Texas

More information

Drug Treatment in Type 2 Diabetes with Hypertension

Drug Treatment in Type 2 Diabetes with Hypertension Hypertension is 1.5 2 times more prevalent in Type 2 diabetes (prevalence up to 80 % in diabetic subjects). This exacerbates the risk of cardiovascular disease by ~ two-fold. Drug therapy reduces the risk

More information

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What

More information

Understanding diabetes Do the recent trials help?

Understanding diabetes Do the recent trials help? Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.

More information

Yul D. Ejnes, MD, MACP Clinical Associate Professor of Medicine Warren Alpert Medical School of Brown University Chair-Emeritus, Board of Regents

Yul D. Ejnes, MD, MACP Clinical Associate Professor of Medicine Warren Alpert Medical School of Brown University Chair-Emeritus, Board of Regents Yul D. Ejnes, MD, MACP Clinical Associate Professor of Medicine Warren Alpert Medical School of Brown University Chair-Emeritus, Board of Regents American College of Physicians Yul D. Ejnes, MD, MACP Has

More information

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations & AF Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations Frequent symptom Less than 50% associated with arrhythmia

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

SUMMARY OF CHANGES TO QOF 2015/16 - ENGLAND CLINICAL

SUMMARY OF CHANGES TO QOF 2015/16 - ENGLAND CLINICAL SUMMARY OF CHANGES TO QOF 2015/1 - ENGLAND KEY No change Retired/replaced Wording and/or change Point or threshold change Indicator ID change 14/15 QOF ID 15/1 QOF ID NICE ID Indicator wording Changes

More information

survival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156

survival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156 introduction 152 < mortality in high- & low-risk patients 154 < predictors of mortality 156 < impact of anemia & dialysis therapy on mortality 158 < mortality in esrd patients with rare s 16 < expected

More information

Cardiovascular Disease Risk Factors

Cardiovascular Disease Risk Factors Cardiovascular Disease Risk Factors Risk factors are traits and life-style habits that increase a person's chances of having coronary artery and vascular disease. Some risk factors cannot be changed or

More information

African Americans & Cardiovascular Diseases

African Americans & Cardiovascular Diseases Statistical Fact Sheet 2013 Update African Americans & Cardiovascular Diseases Cardiovascular Disease (CVD) (ICD/10 codes I00-I99, Q20-Q28) (ICD/9 codes 390-459, 745-747) Among non-hispanic blacks age

More information

on behalf of the AUGMENT-HF Investigators

on behalf of the AUGMENT-HF Investigators One Year Follow-Up Results from AUGMENT-HF: A Multicenter Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Heart Failure* Douglas

More information

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA A CASE STUDY EXAMINING RISK FACTORS AND COSTS OF UNCONTROLLED HYPERTENSION ISPOR 2013 WORKSHOP

More information

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering

More information

EVALUATION OF MEDICAL RECORDS COMPLETENESS IN THE ADULT CARDIOLOGY CLINIC AT NORK MARASH MEDICAL CENTER

EVALUATION OF MEDICAL RECORDS COMPLETENESS IN THE ADULT CARDIOLOGY CLINIC AT NORK MARASH MEDICAL CENTER American University of Armenia Center for Health Services Research and Development Nork Marash Medical Center EVALUATION OF MEDICAL RECORDS COMPLETENESS IN THE ADULT CARDIOLOGY CLINIC AT NORK MARASH MEDICAL

More information

Snoring and Obstructive Sleep Apnea (updated 09/06)

Snoring and Obstructive Sleep Apnea (updated 09/06) Snoring and Obstructive Sleep Apnea (updated 09/06) 1. Define: apnea, hypopnea, RDI, obstructive sleep apnea, central sleep apnea and upper airway resistance syndrome. BG 2. What are the criteria for mild,

More information

Journal of Hypertension 2005, 23:505 511. a Department of Computer Science, b Applied Computing Institute of the Faculty

Journal of Hypertension 2005, 23:505 511. a Department of Computer Science, b Applied Computing Institute of the Faculty Original article 505 A reliable index for the prognostic significance of blood pressure variability Luis Mena a, Salvador Pintos b, Nestor V. Queipo b, José A. Aizpúrua c, Gladys Maestre c and Tulio Sulbarán

More information

Use of antihypertensive medications in patients with diabetes in Ajman, UAE

Use of antihypertensive medications in patients with diabetes in Ajman, UAE Use of antihypertensive medications in patients with diabetes in Ajman, UAE Mohammed Arifulla 1*, Lisha J John 1, Jayadevan Sreedharan 2, Jayakumary Muttappallymyalil 2, Jenny Cheriathu 3, Sheikh Altaf

More information

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME 1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME Izet Aganović, Tina Dušek Department of Internal Medicine, Division of Endocrinology, University Hospital Center Zagreb, Croatia 1 Introduction The metabolic syndrome

More information

DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD

DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Elhami et al. SJIF Impact Factor 5.210 Volume 4, Issue 11, 1159-1166 Research Article ISSN 2278 4357 DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE

More information

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus Melissa Meredith M.D. Diabetes mellitus is a group of metabolic diseases characterized by high blood glucose resulting from defects in insulin secretion, insulin action, or both Diabetes is a chronic,

More information

Carcinoid Hjärtsjukdom

Carcinoid Hjärtsjukdom Carcinoid Hjärtsjukdom CARCINOID TUMORS 20/milj/år FORE-GUT 10% bronchial pancreatic gastric duodenal MID-GUT 70% 40% appendiceal jejunal 30% (6/m/år) ileal prox colonic HIND-GUT 20% distal colonic rectal

More information

Measurement of Blood Pressure

Measurement of Blood Pressure Measurement of Blood Pressure Ambulatory and Home Blood Pressure Monitoring BHS Non Medical Prescribing Update MSc. Management of Hypertension in Primary Care University of Birmingham February 2013 Louise

More information

Diseases and Health Conditions that can Lead to Daytime Sleepiness

Diseases and Health Conditions that can Lead to Daytime Sleepiness October 21, 2014 Diseases and Health Conditions that can Lead to Daytime Sleepiness Indira Gurubhagavatula, MD, MPH Associate Professor Director, Occupational Sleep Medicine University of Pennsylvania,

More information

OEM MAXNIBP Frequently Asked Questions

OEM MAXNIBP Frequently Asked Questions Frequently Asked Questions Why does the monitor sometimes inflate the BP cuff, then shortly thereafter reinflate the cuff? How will I know if the monitor is experiencing motion artifact during a measurement?

More information

Effect of smoking on sustained handgrip test and valsalva ratio among smokers: A cross sectional study

Effect of smoking on sustained handgrip test and valsalva ratio among smokers: A cross sectional study Original article: Effect of smoking on sustained handgrip test and valsalva ratio among smokers: A cross sectional study 1Dr Motilal C. Tayade, 2 Dr Nandkumar B Kulkarni 1Assistant Professor and PhD scholar,

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal

More information

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

HYPERTENSION ASSOCIATED WITH RENAL DISEASES RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein

More information

Quantifying Life expectancy in people with Type 2 diabetes

Quantifying Life expectancy in people with Type 2 diabetes School of Public Health University of Sydney Quantifying Life expectancy in people with Type 2 diabetes Alison Hayes School of Public Health University of Sydney The evidence Life expectancy reduced by

More information

Mississippi Delta Health Collaborative Mississippi State Department of Health 1

Mississippi Delta Health Collaborative Mississippi State Department of Health 1 The Impact of Community Health Workers on Cardiovascular Risk Reduction : Findings from the Clinical Community Health Worker Initiative Mississippi Delta Health Collaborative Mississippi State Department

More information

Vtial sign #1: PULSE. Vital Signs: Assessment and Interpretation. Factors that influence pulse rate: Importance of Vital Signs

Vtial sign #1: PULSE. Vital Signs: Assessment and Interpretation. Factors that influence pulse rate: Importance of Vital Signs Vital Signs: Assessment and Interpretation Elma I. LeDoux, MD, FACP, FACC Associate Professor of Medicine Vtial sign #1: PULSE Reflects heart rate (resting 60-90/min) Should be strong and regular Use 2

More information

Diabetes and the Kidneys

Diabetes and the Kidneys Diabetes and the Kidneys Aim(s) and objective(s) This guideline focuses on the detection, prevention, and management of kidney disease in people with diabetes. The management of end-stage renal disease

More information

Prognostic impact of uric acid in patients with stable coronary artery disease

Prognostic impact of uric acid in patients with stable coronary artery disease Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,

More information

Hypertension Guideline V4

Hypertension Guideline V4 Hypertension Guideline V4 Approved 24/06/2008 Version VERSION 4 FINAL Date of First Issue 26/02/08 Review Date 01/03/2010 Date of Issue 24/06/2008 EQIA Yes / No 24/06/2008 Author / Contact Dr Leslie Cruickshank

More information

Prevalence of Diabetic Retinopathy: A Pilot Study from the SEARCH for Diabetes in Youth Study

Prevalence of Diabetic Retinopathy: A Pilot Study from the SEARCH for Diabetes in Youth Study Prevalence of Diabetic Retinopathy: A Pilot Study from the SEARCH for Diabetes in Youth Study Elizabeth J Mayer-Davis, PhD University of North Carolina at Chapel Hill For the SEARCH Study Group, May 2014

More information

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI

More information

Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial

Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial Appropriate in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial Robert W Schrier*, Raymond O Estacio, Philip S Mehler and William R Hiatt SUMMARY The hypertensive and

More information

In many diabetes units, people with type

In many diabetes units, people with type Renal Microalbuminuria: Screening and management in type 2 diabetes Julia Arundale Introduction In many diabetes units, patients with type 1 or type 2 diabetes are screened for proteinuria. Screening for

More information

Steno Diabetes Center

Steno Diabetes Center Steno Diabetes Center Offentligt hospital Steno Diabetes Center 5.500 patienter tilknyttet - 600-700 nye patienter hvert år Ca 25.000 ambulante konsultationer per år - læger, sygeplejersker, dietister,

More information

Original Research Paper

Original Research Paper 1 of 6 Original Research Paper Age at diagnosis and family history in Type II diabetes: implications for office screening Ching-Ye Hong MBBS, MCGP, FAFP, FRACGP Kee-Seng Chia MBBS, MSc (OM), MD Ching-Ye

More information

PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT

PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT Diabetic nephropathy affects people with either type 1 or type 2 diabetes mellitus.

More information

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011

More information

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center

More information

Correspondence to: Rima B Shah (rima_1223@yahoo.co.in) DOI: 10.5455/ijmsph.2013.2.167-172 Received Date: 29.11.2012 Accepted Date: 03.12.

Correspondence to: Rima B Shah (rima_1223@yahoo.co.in) DOI: 10.5455/ijmsph.2013.2.167-172 Received Date: 29.11.2012 Accepted Date: 03.12. RESEARCH ARTICLE STUDY OF UTILIZATION PATTERN OF ANTI-HYPERTENSIVE DRUGS IN HYPERTENSIVE DIABETIC PATIENTS WITH OR WITHOUT REDUCED RENAL FUNCTION AT TERTIARY CARE TEACHING HOSPITAL Jay Shah 1, Tejas Khakhkhar

More information

Summary. Master-/Bachelor Thesis

Summary. Master-/Bachelor Thesis Summary Master-/Bachelor Thesis "The regulating effect of breathing- therapeutic interventions relating to the autonomic nervous system" Gabriele Pieper Background Like many of the complementary methods

More information

a Centre de Médecine Cardiovasculaire, Paris, France and b Lebanese Received 7 June 2009 Revised 6 September 2009 Accepted 17 September 2009

a Centre de Médecine Cardiovasculaire, Paris, France and b Lebanese Received 7 June 2009 Revised 6 September 2009 Accepted 17 September 2009 Devices and technology 49 Validation of three automatic devices for self-measurement of blood pressure according to the International Protocol: The Omron M3 Intellisense (HEM-71-E), the Omron M2 Compact

More information

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic

More information

Mortality Assessment Technology: A New Tool for Life Insurance Underwriting

Mortality Assessment Technology: A New Tool for Life Insurance Underwriting Mortality Assessment Technology: A New Tool for Life Insurance Underwriting Guizhou Hu, MD, PhD BioSignia, Inc, Durham, North Carolina Abstract The ability to more accurately predict chronic disease morbidity

More information

Scottish Diabetes Survey

Scottish Diabetes Survey Scottish Diabetes Survey 2011 Scottish Diabetes Survey Monitoring Group Foreword The Scottish Diabetes Survey 2011 data reflects many aspects of the quality of diabetes care across the whole of Scotland.

More information

Reports from Framingham and from other studies have

Reports from Framingham and from other studies have Impact of Diabetes on Cardiac Structure and Function The Strong Heart Study Richard B. Devereux, MD; Mary J. Roman, MD; Mary Paranicas, BA; Michael J. O Grady, BA; Elisa T. Lee, PhD; Thomas K. Welty, MD,

More information

Appendix: Description of the DIETRON model

Appendix: Description of the DIETRON model Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough

More information